Evidence map›Paper›PMID 32724648›Full record

ArticleFood science & nutrition2020

Oligosaccharide attenuates aging-related liver dysfunction by activating Nrf2 antioxidant signaling.

Yueming Wang, Yanlei Xiong, Aiping Zhang, Nannan Zhao, Jiashen Zhang, Dongmei Zhao, Zhenhai Yu, Ning Xu, Yancun Yin, Xiying Luan and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 37 citations in OpenAlex.

  1. Combination Effects ofBiology · 2026
    Article
  2. Article
  3. The Potential of Superoxide Dismutase-RichInternational journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Effects of Amazake Produced with DifferentFoods (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yueming WangDepartment of Anatomy School of Basic Medicine Binzhou Medical University Yantai China.
Yanlei XiongDepartment of Pathology Xuanwu Hospital Capital Medical University Beijing China.
Aiping ZhangDepartment of Immunology School of Basic Medicine Binzhou Medical University Yantai China.
Nannan ZhaoDepartment of Immunology School of Basic Medicine Binzhou Medical University Yantai China.
Jiashen ZhangDepartment of Anatomy School of Basic Medicine Binzhou Medical University Yantai China.
Dongmei ZhaoDepartment of Anatomy School of Basic Medicine Binzhou Medical University Yantai China.
Zhenhai YuDepartment of Anatomy School of Basic Medicine Binzhou Medical University Yantai China.
Ning XuDepartment of Anatomy School of Basic Medicine Binzhou Medical University Yantai China.
Yancun YinDepartment of Anatomy School of Basic Medicine Binzhou Medical University Yantai China.
Xiying LuanDepartment of Immunology School of Basic Medicine Binzhou Medical University Yantai China.
Yanlian XiongDepartment of Anatomy School of Basic Medicine Binzhou Medical University Yantai China.ORCID https://orcid.org/0000-0001-5178-8932
Binzhou Medical University · CNBinzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chitosan oligosaccharide (COS) is the depolymerized product of chitosan possessing various biological activities and protective effects against inflammation and oxidative injury. The aim of the present study was to investigate the antioxidant effects of COS supplements on aging-related liver dysfunction. We found that COS treatment significantly attenuated elevated liver function biomarkers and oxidative stress biomarkers and decreased antioxidative enzyme activities in liver tissues in D-galactose (D-gal)-treated mice. Furthermore, COS treatment significantly upregulated the expression of Nrf2 and its downstream target genes HO-1, NQO1, and CAT. Moreover, in vitro experiments showed that COS treatment played a vital role in protecting H

Indexed as

anti‐agingchitosan oligosaccharideD‐galactoseliverNrf2 pathway

Identifiers

PMID32724648
PMCPMC7382186
OpenAlexW3033625385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.